World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
23227
World Ranking
15218
National Ranking
7677

Overview

Thomas A. Aloia is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily spans medicine with a focus on oncology, surgery, and hepatology. Additional areas of study include economics and econometrics, as well as public health, environmental, and occupational health.

Their work covers a range of topics, notably:

  • Hepatocellular carcinoma treatment and prognosis
  • Pancreatic and hepatic oncology research
  • Colorectal cancer treatments and studies
  • Economic and financial impacts of cancer
  • Enhanced recovery after surgery
  • Cholangiocarcinoma and gallbladder cancer studies
  • COVID-19 and healthcare impacts

Thomas A. Aloia has published extensively in several journals. The most frequent publication venues include:

  • Gastroenterology
  • Annals of Surgical Oncology
  • HPB
  • Annals of Surgery
  • Journal of Gastrointestinal Surgery

The scientist has collaborated regularly with several co-authors, among whom the most frequent are:

  • Ching-We D. Tzeng
  • Yun Shin Chun
  • Timothy E. Newhook
  • Jean-Nicolas Vauthey
  • Hop S. Tran Cao

Several notable papers authored or co-authored by Thomas A. Aloia include:

  • "Guidelines for Perioperative Care for Pancreatoduodenectomy: Enhanced Recovery After Surgery (ERAS) Recommendations 2019," 2020, World Journal of Surgery
  • "Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons," 2020, Annals of Surgery
  • "Time to Rethink Upfront Surgery for Resectable Intrahepatic Cholangiocarcinoma? Implications from the Neoadjuvant Experience," 2021, Annals of Surgical Oncology
  • "A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status," 2020, Journal of the National Comprehensive Cancer Network
  • "Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status," 2021, British Journal of Surgery

Best Publications

  • Liver Histology and Surgical Outcomes After Preoperative Chemotherapy With Fluorouracil Plus Oxaliplatin in Colorectal Cancer Liver Metastases

    Thomas A Aloia;Mylène Sebagh;Marylène Plasse;Vincent Karam

  • Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic Model

    René Adam;Laurence Chiche;Thomas A Aloia;Dominique Elias

  • Solitary Colorectal Liver Metastasis: Resection Determines Outcome

    Thomas A. Aloia;Jean Nicolas Vauthey;Evelyne M. Loyer;Dario Ribero

  • Is liver resection justified for patients with hepatic metastases from breast cancer

    René Adam;Thomas A Aloia;Jinane Krissat;Marie Pierre Bralet

  • Gallbladder cancer: expert consensus statement.

    Thomas A. Aloia;Nicolas Járufe;Milind Javle;Shishir K. Maithel

  • Hilar Cholangiocarcinoma: expert consensus statement

    John C. Mansour;Thomas A. Aloia;Christopher H. Crane;Julie K. Heimbach

  • RAS mutation status predicts survival and patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.

    Jean Nicolas Vauthey;Giuseppe Zimmitti;Scott E. Kopetz;Junichi Shindoh

  • Complete Pathologic Response After Preoperative Chemotherapy for Colorectal Liver Metastases: Myth or Reality?

    René Adam;Dennis A Wicherts;Robbert J de Haas;Thomas Aloia

  • Selection for hepatic resection of colorectal liver metastases: expert consensus statement

    Reid B. Adams;Thomas A. Aloia;Evelyne Loyer;Timothy M. Pawlik

  • Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant

    Junichi Shindoh;Mark J. Truty;Thomas A. Aloia;Steven A. Curley

  • A Proposed Staging System for Intrahepatic Cholangiocarcinoma

    Hari Nathan;Thomas A. Aloia;Jean Nicolas Vauthey;Eddie K. Abdalla

  • Analysis of the efficacy of portal vein embolization for patients with extensive liver malignancy and very low future liver remnant volume, including a comparison with the associating liver partition with portal vein ligation for staged hepatectomy approach

    Junichi Shindoh;Jean Nicolas Vauthey;Giuzeppe Zimmitti;Steven A. Curley

  • Ablative Radiotherapy Doses Lead to a Substantial Prolongation of Survival in Patients With Inoperable Intrahepatic Cholangiocarcinoma: A Retrospective Dose Response Analysis

    Randa Tao;Sunil Krishnan;Priya R. Bhosale;Milind M. Javle

  • Parenchymal-sparing Hepatectomy in Colorectal Liver Metastasis Improves Salvageability and Survival.

    Yoshihiro Mise;Thomas A. Aloia;Kristoffer W. Brudvik;Lilian Schwarz

  • Liver transplantation for locally advanced intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: a prospective case-series.

    Keri E Lunsford;Milind Javle;Kirk Heyne;Rachna T Shroff

  • Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy.

    René Adam;Thomas A Aloia;Francis Lévi;Dennis A. Wicherts

  • Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement

    René Adam;Robbert J. de Haas;Dennis A. Wicherts;Thomas A. Aloia

  • Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.

    Junichi Shindoh;Xabier de Aretxabala;Thomas A Aloia;Juan C arlos Roa

  • Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point Before Resection of Hepatic Colorectal Metastases

    Junichi Shindoh;Evelyne M. Loyer;Scott Kopetz;Piyaporn Boonsirikamchai

  • Margin status remains an important determinant of survival after surgical resection of colorectal liver metastases in the era of modern chemotherapy.

    Andreas Andreou;Thomas A. Aloia;Antoine Brouquet;Paxton V. Dickson

Frequent Co-Authors

Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center
Scott Kopetz
Scott Kopetz The University of Texas MD Anderson Cancer Center
Cathy Eng
Cathy Eng Vanderbilt University
J. Jack Lee
J. Jack Lee The University of Texas MD Anderson Cancer Center
Xuemei Wang
Xuemei Wang The University of Texas MD Anderson Cancer Center
Timothy M. Pawlik
Timothy M. Pawlik The Ohio State University Wexner Medical Center
James L. Abbruzzese
James L. Abbruzzese Duke University
Jennifer A. Chan
Jennifer A. Chan University of Calgary
Andrew X. Zhu
Andrew X. Zhu Harvard University
Richard D. Schulick
Richard D. Schulick University of Colorado Anschutz Medical Campus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in the healthcare field but not sure if medical school is the right fit? There are a range of rewarding online degree programs and alternative pathways to a medical career. For those who prefer an administrative role, a healthcare administration online degree can prepare you for leadership positions in hospitals, clinics, or insurance organizations—all from the comfort of your home.

If you’re focused on quick entry into the workforce, medical billing and coding offers fast-track options. Explore top medical billing and coding online schools, many of which provide flexible schedules and financial aid opportunities.

Nursing is another in-demand field with streamlined online options. Curious about prerequisites? Find out, for example, do I need to take the teas test for LPN and learn more about programs that remove traditional testing barriers.

For registered nurses aiming to advance, bridge programs like the ASN to NP path help expedite the route to nurse practitioner roles—boosting career growth without pressing pause on your professional life.

Best Scientists Citing Thomas A. Aloia

Trending Scientists